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Abstract
Background: TGIF and TGIF2 are homeodomain proteins, which act as TGFβ specific Smad
transcriptional corepressors. TGIF recruits general repressors including mSin3 and CtBP. The
related TGIF2 protein functions in a similar manner, but does not bind CtBP. In addition to
repressing TGFβ activated gene expression, TGIF and TGIF2 repress gene expression by binding
directly to DNA. TGIF and TGIF2 share two major blocks of similarity, encompassing the
homeodomain, and a conserved carboxyl terminal repression domain. Here we characterize two
splice variants of the Tgif2 gene from mouse and demonstrate that the Tgif2 gene contains a
retained intron.
Results: By PCR from mouse cDNA, we identified two alternate splice forms of the Tgif2 gene.
One splice variant encodes the full length 237 amino acid Tgif2, whereas the shorter form results
in the removal of 39 codons from the centre of the coding region. The generation of this alternate
splice form occurs with the mouse RNA, but not the human, and both splice forms are present in
all mouse tissues analyzed. Human and mouse Tgif2 coding sequences contain a retained intron,
which in mouse Tgif2 is removed by splicing from around 25–50% of RNAs, as assessed by RT-PCR.
This splicing event is dependent on sequences within the mouse Tgif2 coding sequence. Both splice
forms of mouse Tgif2 encode proteins which are active transcriptional repressors, and can repress
both TGFβ dependent and independent transcription. In addition, we show that human and mouse
Tgif2 interact with the transcriptional corepressor mSin3.
Conclusion: These data demonstrate that the Tgif2 gene contains a retained intron, within the
second coding exon. This retained intron is not removed from the human mRNA at a detectable
level, but is spliced out in a significant proportion of mouse RNAs. This alternate splicing is
dependent entirely on sequences within the mouse Tgif2 coding sequence, suggesting the presence
of an exonic splicing enhancer. Both splice forms of mouse Tgif2 produce proteins which are
functional transcriptional repressors.
Background
TGIF (thymine guanine interacting factor) is a homeodo-
main containing protein which was first identified by its
ability to bind adjacent to a specific retinoic acid response
element [1]. TGIF is a transcriptional repressor, which
interacts with general corepressors, including CtBP and
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Loss of function mutations in human TGIF are associated
with holoprosencephaly (HPE), a severe genetic disease
affecting craniofacial development [6-8]. A human TGIF
related protein (TGIF2) has been identified, which shares
at least some functions with TGIF [9,10]. TGIF and TGIF2
are also transcriptional corepressors for TGFβ receptor
activated Smads [9,11]. TGIF interacts specifically with
Smad2 and Smad3, and is thought to limit the magnitude
of the transcriptional response to TGFβ signaling. In
response to the binding of TGFβ to its cognate receptors,
the activated receptor complex phosphorylates and acti-
vates specific receptor Smad (R-Smad) proteins: Smad2 or
Smad3 in the case of TGFβ and activin [12-14]. The acti-
vated R-Smads then complex with the co-Smad, Smad4
and accumulate in the nucleus, where they activate expres-
sion of specific target genes. The Smad proteins them-
selves can bind to DNA, and are also recruited to specific
response elements via interactions with other sequence
specific DNA binding proteins [15-20]. Once bound to a
specific target DNA element, a Smad complex activates
transcription via interactions with general coactivators,
such as p300/CBP [21-24]. In addition to coactivator
interactions, Smads can also interact with specific tran-
scriptional corepressors, including TGIF and TGIF2
[9,11], c-Ski and the related SnoN [25-28]. These interac-
tions result in a loss of activation due to displacement of
the coactivator complex, and active repression of gene
expression by the recruitment of general corepressors
[11,17,29]. It is likely that the relative abundance of Smad
coactivators and corepressors within a cell is a major
determinant of the magnitude of the transcriptional
response to TGFβ.
Since human TGIF and TGIF2 appear to be relatively
divergent in primary amino acid sequence outside the two
main blocks of homology [9,30], we wanted to identify
and characterize TGIF2 from another species. Here we
report the cloning and characterization of mouse Tgif2, as
well as the identification of an unusual splice variant of
the mouse Tgif2 gene. Analysis of this splice variant sug-
gests that the TGIF2 genes from both human and mouse
contain a retained intron, which is spliced out of a propor-
tion of mouse Tgif2 RNAs.
Results
Two splice forms of mouse Tgif2
We isolated clones for mouse Tgif2 by PCR from 11 day
mouse embryo cDNA using primers at the extreme 5' and
3' ends of the coding sequence. A band of the expected
size for Tgif2 was amplified from this cDNA, and a faster
migrating band was also present (Figure 1A and data not
shown). Each of these DNA fragments was cloned and
sequenced: The slower migrating form represented a
mouse Tgif2 clone encoding a predicted 237 amino acid
protein with only 13 amino acid differences from the
human protein (see Figure 2). Interestingly, the faster
migrating DNA fragment also contained a form of mouse
Tgif2, but was lacking 117 base pairs from the centre of
the cDNA. Inspection of the sequences that are missing in
this clone revealed the presence of 5' and 3' splice sites as
well as a 5/6 match to the branch point consensus
sequence [31], suggesting that this deletion is caused by
alternate splicing (Figure 1B). The branch point sequence
is less well conserved (3/6 match) in the human TGIF2
gene, and we have been unable to amplify a similar form
of human TGIF2 from cDNA (Figure 1A and data not
shown). Thus, it appears that this alternately spliced form
of Tgif2 (which we term Tgif2d) is not found to a signifi-
cant degree in humans.
To determine how wide-spread the expression of the two
splice forms of mTgif2 is, we PCR amplified mTgif2
cDNAs from a panel of mouse tissues. In all adult tissues
where mTgif2 was detected, both forms of the mRNA were
present, and both splice forms were present from day 7 of
embryonic development (Figure 1A). In all tissues tested,
the mTgif2d splice form was readily detectable by this RT-
PCR assay. However, we have not carried out accurate
quantification of the relative amounts of each splice form
in multiple tissues.
Two splice forms of mouse Tgif2Figure 1
Two splice forms of mouse Tgif2. A) Expression of 
mouse Tgif2 was analyzed by PCR from 1st strand cDNA, 
using primers at the 5' and 3' ends of the coding sequence. 
cDNAs were from the tissues indicated (sk. musc = skeletal 
muscle), or from embryos at the indicated days of gestation. -
ve: no cDNA. Similar PCR analysis was carried out on cDNA 
from human brain and kidney (right). B) Alignment of puta-
tive splice sequences from mouse and human TGIF2 with 
splice consensus sequences (matches to the consensus are 
shaded gray).Page 2 of 10
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Multiple forms of the mouse TGIF2 proteinFigure 2
Multiple forms of the mouse TGIF2 protein. A) alignment of human TGIF2 and mouse Tgif2 and Tgif2d protein sequence. 
Differences between human and mouse are shaded. Dashes indicate amino acids missing in mTGIF2d. The homeodomain and 
carboxyl-terminal extension are boxed. The carboxyl-terminal region of TGIF2 which is conserved in TGIF is indicated by a 
dashed box. MAP kinase phosphorylation sites are boxed, and threonine to valine mutations are indicated below. B) Alignment 
of the carboxyl-terminal part of the homeodomain and extension from TGIFs of different species. TGIF2: human, mouse; TGIF: 
human, mouse, chicken, Xenopus, zebra fish; Drosophila dTGIFa and dTGIFb. Residues identical between all are shaded black, 
similar are gray. The homeodomain is boxed and the arrow indicates the position affected by alternate splicing of mTgif2. COS-
1 cells were transfected with the indicated Flag-tagged expression constructs (C) or with Flag-mTGIF2 or a mutant in which 
two threonines were altered to valine (D). Protein expression was analyzed by western blotting with a Flag specific antibody.
BMC Molecular Biology 2006, 7:2 http://www.biomedcentral.com/1471-2199/7/2Both splice forms of Mouse Tgif2d produce proteins
The predicted proteins from the human and mouse Tgif2
genes are highly conserved, with 94% identity over the
entire protein (Figure 2A). For comparison, TGIFs from
these species are 89% identical. There are two regions of
conservation between TGIF and TGIF2: The homeodo-
main plus a 20 amino acid carboxyl-terminal extension
which is characteristic of TGIFs (Figure 2A, boxed), and a
region near the carboxyl-termini of the proteins (Figure
2A, dashed box). As shown in Figure 2A, alternate splicing
of mTgif2 removes part of the central linker joining the
two regions of conservation between TGIF and TGIF2 pro-
teins. We previously characterized two TGIF related pro-
teins from Drosophila, that have a high degree of identity
to vertebrate TGIFs in the homeodomain and the car-
boxyl-terminal extension [30], which is conserved in ver-
tebrate TGIFs (Figure 2B). Interestingly, alternate splicing
of mTgif2 retains the homeodomain and almost all of the
conserved region carboxyl terminal to it, suggesting that
the homeodomain plus carboxyl-terminal extension
(HD+20) is not disrupted in mTgif2d.
To test whether the alternate splice form of mTgif2 is
expressed as a stable protein product, we transfected COS-
1 cells with Flag-tagged versions of human and mouse
TGIF2 and mTgif2d. The human TGIF2 protein migrates
as two, or three bands (the slowest migrating band is often
seen with higher levels of expression) of apparent molec-
ular weight of 30–32 kD (Figure 2C). This results from
phosphorylation of two conserved MAP kinase sites
within the carboxyl terminal region of the protein [9]. In
cells expressing mTgif2, three bands in the 30–32 kD
range were present, as well as a group of three bands with
faster mobility (Figure 2C). The difference in mobility
between these two triplets is consistent with the removal
of approximately 4 kD predicted by removal of 39 codons
from the centre of the coding sequence. Expression of the
mTgif2d isoform resulted in the presence only of the
lower group of bands. Alteration of the two threonine res-
idues within the conserved MAP kinase sites to valines
within mTgif2 (see Figure 2A) resulted in the presence of
only two bands, suggesting that as with the human TGIF2
[9] the upper bands are due to phosphorylation of these
residues (Figure 2D). Thus, it appears that multiple forms
of mouse Tgif2 are created both by alternate splicing and
phosphorylation.
Mouse Tgif2d encodes a functional repressor which 
interacts with mSin3
To determine whether the mTgif2d protein functions in a
similar manner to the longer splice form, we first looked
at interactions with the general corepressor, mSin3. TGIF
interacts with the corepressor mSin3 via its carboxyl ter-
minal repression domain, which is conserved in human
and mouse TGIF2 [4]. However, interaction of mSin3
with Tgif2 from mouse or human has not been demon-
strated. COS-1 cells were transfected with expression con-
structs encoding Flag-tagged human or mouse TGIF2, or
Flag-mTgif2d and Myc epitope-tagged mSin3. Protein
complexes were isolated on Flag agarose and analyzed for
the presence of Myc-Sin3. Both human and mouse TGIF2
interacted with mSin3, as did the mTgif2d splice variant,
whereas, no interaction was seen with a carboxyl-terminal
truncation mutant of hTGIF (Figure 3A). To test whether
mTgif2d can repress transcription, we expressed either
mTgif2 or mTgif2d in HepG2 cells and monitored expres-
sion of a luciferase reporter gene in which expression is
driven by the TK promoter and two copies of a TGIF bind-
ing site (CTGTCAA). As shown in Figure 3B, both the full
length mTgif2 and mTgif2d repressed expression of this
reporter, suggesting that both splice forms are transcrip-
tional repressors.
Both TGIF and human TGIF2 interact with TGFβ respon-
sive Smads and repress transcription from TGFβ respon-
sive reporters [9,11]. To determine whether alternate
splicing of mouse Tgif2 affected interaction with TGFβ
activated Smads, COS-1 cells were cotransfected with
Smad2 or Smad3 expression plasmids together with
human or mouse TGIF2. Smad3 clearly coprecipitated
with both full length human and mouse TGIF2 and with
the mTgif2d splice variant (Figure 3C). Similarly, Smad2
interacted with both forms of mouse Tgif2. However, we
observed no interaction of Smad3 with a truncation
mutant encoding amino acids 2–105 of hTGIF2 (Figure
3C). Together, these results suggest that sequences car-
boxyl-terminal to the homeodomain of TGIF2 are
required for interaction with Smad3, and that the central
region of the TGIF2 protein is dispensable for interaction
with TGFβ activated Smads. To test whether the interac-
tion of mTgif2d with Smad2 and Smad3 resulted in
repression of TGFβ transcriptional responses, we cotrans-
fected HepG2 cells with the 3TP-lux reporter and expres-
sion vectors encoding either human TGIF or TGIF2, or
mouse Tgif2d. As shown in Figure 3D, all three proteins
repressed the expression of this reporter in the presence of
added TGFβ, although TGIF appeared to repress more
effectively. These results suggest that both full length and
the shorter isoform of mouse Tgif2 can act as Smad tran-
scriptional corepressors.
A retained intron in the second coding exon of Tgif2
To compare expression of human and mouse Tgif2
mRNAs in transfected cells, we generated expression vec-
tors containing only the 237 amino acid ORFs from either
species. As shown in Figure 4A (lane 1), RT-PCR analysis
of RNA from COS-1 cells transiently transfected with a
mTgif2 expression construct revealed the presence of both
mTgif2 splice forms. In contrast, similar analysis of COS-1
cells transfected with the human TGIF2 ORF revealed onlyPage 4 of 10
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The mouse Tgif2d protein is a functional repressorFigure 3
The mouse Tgif2d protein is a functional repressor. A) COS-1 cells were cotransfected with myc-tagged mSin3A and 
the indicated Flag-tagged expression constructs. Proteins were isolated on Flag agarose and analyzed for coprecipitating 
mSin3A with a myc antibody. Expression of transfected proteins in cell lysates is shown below. B) HepG2 cells were trans-
fected with a reporter in which the luciferase gene is driven by the TK promoter and two TGIF binding sites, together with 
increasing amounts of mTgif2 or mTgif2d. Luciferase activity was assayed after 36 hours and is shown compared to a control 
transfection (mean +/- s.d. of triplicate transfections). C) COS-1 cells were cotransfected with a Smad2 or Smad3 expression 
vector and the indicated Flag-tagged expression constructs. Proteins were isolated on Flag agarose and analyzed for coprecipi-
tating Smad2 or Smad3. Expression of transfected proteins in cell lysates is shown below. D) HepG2 cells were transfected 
with the 3TP-lux reporter, together with human TGIF, TGIF2 or mouse Tgif2d. After 24 hours, cells were treated with TGFβ 
(100 pM), or left untreated and luciferase activity was assayed 16 hours later, and is shown as the mean +/- s.d. of triplicate 
transfections.
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ORF (lane 2). For comparison, we also performed PCR
reactions directly on plasmids containing the long and
short forms of mTgif2 and obtained a single band of the
expected size for each (Figure 4A, lanes 3 and 4). This sug-
gests that alternate splicing of Tgif2 is specific to the
mouse gene and independent of cell type. Additionally, it
appears that the splicing event is dependent on the nucle-
otide sequence of the mTgif2 coding region. These data
suggest that the mouse Tgif2 transcript can undergo mul-
tiple splicing events: Removal of the first and second
introns from all RNAs, and removal of part of the second
coding exon from a proportion of mTgif2 RNAs (Figure
4B). Thus the second coding exon of mTgif2 appears to
contain a small intron, which is retained in at least half
the mRNAs. In contrast, in the human mRNA, this intron
is always retained, or removed at an extremely low fre-
quency, below our level of detection.
Analysis of the sequences required for alternate splicing
The previous data suggest that the mTgif2 coding region
contains sequence information which directs alternate
splicing, and this information is not present in the
human. To determine which region of the mTgif2 RNA is
required for alternate splicing, we first made a series of
swaps between human and mouse Tgif2. The coding
region was divided into three segments: The retained
intron and the regions 5' and 3' to it. COS-1 cells were
transfected with expression vectors containing these chi-
meric cDNAs and mRNAs were analyzed by RT-PCR. As
shown in Figure 5A, both the retained intron and the
region 3' of it from the mouse gene were required for alter-
nate splicing (construct HMM). In contrast, constructs
with either the 3' region alone (HHM), or both the
retained intron and the 5' region (MMH) from the mouse
did not splice out the retained intron. To determine
whether sequences within the 3' region were inhibitory in
the human gene or promoted splicing in the mouse gene,
we tested two deletion constructs each for the human and
mouse cDNAs. Neither of the human deletion constructs
underwent alternate splicing, and the mouse 1–432 con-
struct produced only a single splice form (Figure 5B). The
intermediate deletion (1–531) resulted in a very low level
of the alternate splice form, suggesting that the 3' coding
region of the mouse gene contains sequences which
enhance splicing. Analysis of a larger series of mTgif2 3'
deletion constructs revealed that sequences 3' of base 645
were not required for alternate splicing (Figure 5C),
whereas further truncation to base 572 dramatically
reduced alternate splicing.
Mouse and human Tgif2 share a high degree of sequence
identity in the 3' region of the coding sequence (89%
identity over the entire coding region). We were, there-
fore, interested to determine whether we could transfer
small regions of the mouse coding sequence to the human
Tgif2 clone and cause it to undergo alternate splicing. We
first altered the sequence surrounding the branch point in
the retained intron from a 3/6 match to a 5/6 match to the
consensus, as in the mouse sequence. As shown in Figure
6A, this change alone did not cause the human sequence
to undergo alternate splicing (lane 3). When this altera-
tion was combined with the mouse 3' region an interme-
diate level of splicing was observed (compare lanes 1, 2
and 3, Figure 6A). Thus, it appears that the branch point
sequence plays a role in determining the differential splic-
ing between human and mouse Tgif2. However, we can-
not rule out contributions of other sequence differences
within the retained intron.
To determine whether there was a simple sequence signal
in the region of the mouse RNA 3' of the retained intron,
we created two constructs in which mouse sequences 3' of
base 543 were combined with the mouse retained intron
(construct HMh) or the mouse 5' region (construct MHh).
Within the chimeric 3' region, bases 410–543 come from
the human and 544–714 from the mouse. This leaves
only 16 base differences between the mouse sequence and
the HMh construct over the retained intron and 3' region
A retained intron in the TGIF2 geneFigure 4
A retained intron in the TGIF2 gene. A) RT-PCR analy-
sis of COS-1 cells transfected with mouse or human TGIF2 
(lanes 1 and 2) or direct PCR on plasmid DNA (lanes 3 and 
4). Positions of the PCR primers are shown to the right. B) A 
schematic representation of splicing events of the mouse 
Tgif2 RNA is shown.Page 6 of 10
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these constructs underwent alternate splicing to any
detectable level (Figure 6A, lanes 4 and 5). This suggests
that if there is a splicing enhancer sequence in the 3' of the
mouse coding sequence it is either relatively large or com-
posed of multiple elements throughout the region.
Together, these results suggest that the mouse Tgif2 coding
sequence contains multiple positively acting signals
which increase the efficiency of alternate splicing to
remove a retained intron. To further explore the species
specificity of the alternate splicing of Tgif2, we performed
RT-PCR analyses on cell lines from different mammalian
species, and searched available sequence databases. Inter-
estingly, Tgif2d splice forms are present in the database
from both mouse and rat, but not for any other vertebrate
species for which Tgif2 clones are present. Consistent with
the results from database searching, we have been unable
to amplify by RT-PCR, or PCR from cDNA libraries a
human or dog Tgif2d splice variant. Thus, it appears that
the Tgif2d splice variant may be specific to rodents.
Discussion
We show that the mouse Tgif2 gene undergoes alternative
splicing, whereas, the human TGIF2 gene appears not to
generate the alternate splice form at any significant level.
Interestingly the alternate splicing seen in the mouse Tgif2
gene is dependent on the coding sequence of the mouse
Tgif2 mRNA. Alternate splicing of the isolated mouse cod-
ing sequence occurs in all cell lines tested, and we did not
detect significant levels of splicing of equivalent human
TGIF2 constructs. Importantly, the pattern of splicing of
the isolated human and mouse coding regions appears to
correlate with that of the endogenous genes. Alternate
splicing of the mouse RNA results in the removal of a
region of the second coding exon, without disrupting the
reading frame. At least half the time, this region is retained
in the mouse RNA and appears to be always retained in
the human. Thus it is possible that the human TGIF2 gene
contains a constitutively retained intron. Searching the
sequence databases for TGIF2 genes from other species
revealed full length coding sequences from rat, cow and
dog. As shown in Figure 5B, 5' and 3' splice sites did not
The 3' coding region of mouse Tgif2 is required for alternate splicingFigure 5
The 3' coding region of mouse Tgif2 is required for alternate splicing. COS-1 cells were transfected with expression 
constructs and expression of human, mouse and chimeric TGIF2 RNAs was analyzed by RT-PCR. The positions of primers are 
indicated (arrows). Alternate splicing: + splicing, - no splicing, -/+ just detectable, +/- slightly reduced. Constructs are shown 
schematically: Gray = mouse, black = retained intron. Stripes = human, crosshatch = retained intron. A) Comparison of con-
structs in which regions 5' and 3' of the retained intron are swapped between human and mouse TGIF2. B) Comparison of 
splicing of 3' deletion constructs for human and mouse TGIF2. C) Analysis of a series of 3' deletions of mouse TGIF2.Page 7 of 10
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was present in the cow sequence. However, the branch
acceptor site in the mouse sequence was closer to the con-
sensus than any of the other species and human and dog
were most different, with 3/6 mismatches. Pairwise com-
parison of the sequences 3' to the retained intron between
these five species revealed a high degree of identity (at
least 84%), which is very similar to that for the entire cod-
ing sequence (Figure 5C). However, the mouse and rat
sequences share 95% identity, whereas all other
sequences are less than 90% identical.
Alternate splicing is likely to be the result of competition
for spliceosome assembly between multiple splice sites,
whereas, for intron retention it may be that the competi-
tion is between spliceosome assembly and RNA export
[32]. In the human TGIF2 RNA, spliceosome assembly is
too inefficient at these sites, whereas in the mouse RNA it
occurs with a high enough efficiency that the retained
intron is removed from a significant proportion of RNAs.
Although this type of alternate splicing is relatively
uncommon in animal cells, compared to the variable use
of alternate splice sites [32,33], database analysis suggests
that up to 14% of human genes have intron retention
events. However, unlike the case reported here, the major-
ity of these were found to be in untranslated regions [33].
We were unable to define a small region within the mouse
Tgif2 coding sequence which promoted splicing, but it
appears that the splicing event is dependent on much of
the second coding exon. In many cases, alternate or regu-
lated splicing is dependent on the presence of splicing
enhancers, which can be located within exons. Splicing
enhancer consensus sequences have been identified, and
shown to bind to SR proteins such as SF2/ASF, SRp40 and
SRp55 [34-37]. Binding of SR proteins to splicing enhanc-
ers is thought to facilitate the recruitment of the splicing
machinery to adjacent introns, which can be several hun-
dred bases distant. Although some matches to splicing
enhancer sequences are present in the mouse Tgif2 coding
sequence, we were unable to identify one which was
responsible for the difference between human and mouse
The branch site sequence contributes to splicing efficiencyFigure 6
The branch site sequence contributes to splicing efficiency. A) Chimeric forms of Tgif2 were analyzed for splicing of 
the retained intron. A mutation of the branch site was introduced into the human TGIF2 sequence. HhH: the sequence of the 
branch acceptor site in the human was altered to that of mouse, HhM: as HhH, with mouse sequence 3' to the retained intron. 
HMh and MHh: the region 3' of the retained intron consisted of human sequences to base 543 and mouse sequence thereafter. 
The other regions of the coding sequence were human (H) or mouse (M) as indicated. B) Comparison of the sequences of the 
splice sites surrounding the retained intron and the branch acceptor site. Sequences from mouse (m), human (h), rat (r), dog 
(d) and cow (c) are shown with the consensus above. Boxed bases differ from the consensus. C) Pairwise sequence compari-
son of the coding sequence 3' of the retained intron (upper) or the entire coding sequences (lower) between the five species 
indicated. Percent identity is shown.Page 8 of 10
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sequences in the region 3' to the retained intron did not
reveal the presence of a splicing enhancer consensus that
was present in the mouse but disrupted by sequence dif-
ferences in the human. Analysis of the coding sequences
of human and mouse Tgif2 reveals the presence of a large
number of predicted exonic splicing enhancer (ESE) con-
sensus sequences (using both ESEFinder; http://
rulai.cshl.edu/tools/ESE/index.html[38] and RESCUE-
ESE; http://genes.mit.edu/burgelab/rescue-ese/[39]). We
were unable to identify clear candidate ESE sequences
which were present only in the mouse and not in the
human, or which had much higher scores in the mouse
than the human sequence. This may fit with our results
which suggest that multiple regions of the mouse coding
sequence promote alternate splicing.
Conclusion
The Tgif2 gene contains a retained intron within the sec-
ond coding exon. In the mouse, this retained intron is
removed by splicing in a significant proportion of
mRNAs, whereas, we have been unable to detect this
splice form of the human TGIF2. It appears that the
mouse Tgif2 coding region 3' of the retained intron con-
tains sequences which promote removal of the retained
intron in a cell type independent manner. In addition,
sequences within the retained intron also contribute to
the efficiency of splicing.
Methods
Cell culture and transfection
HepG2 and COS-1 cells were grown in Dulbecco's modi-
fied essential medium with high glucose and 10% fetal
bovine serum. HepG2 cells were transfected in twelve-well
plates using Exgen 500 (Fermentas) and COS-1 were
transfected using LipofectAMINE (Invitrogen).
Plasmids
3TP-lux contains a TGFβ-inducible promoter region from
the PAI-1 gene and three TPA-response elements [40]. The
(TG)2-TK-luc reporter is as described [5]. TGIF was
expressed from a modified pCMV5 plasmid, with a Flag
tag. Mouse Tgif2 constructs were created in pCMV5-Flag
by PCR. Flag tagged human TGIF2 has been described [9].
Full length human Smad2 and Smad3 were expressed
from pCMV5 without epitope tags and Myc-Sin3 and
hTGIF(1–192) are as described [4]. Point mutations in
mTgif2 were introduced by PCR, and verified by sequence
analysis. hTGIF2(2–105) was created within pCMV5-Flag
by PCR.
Cloning of mouse Tgif2 cDNAs
Mouse Tgif2 was cloned by PCR from day 11 mouse
embryo cDNA (Clontech). Primers, corresponding to the
5' and 3' ends of the expected coding sequence were based
on the human sequence and the partial sequence of an
EST clone, with a 5' EcoRI site and a 3' BamHI site. PCR
products were analyzed by agarose gel electrophoresis and
the two visible bands (approximately 600 bp and 700 bp)
were excised from the gel, digested with EcoRI and BamHI
and ligated into pBSKS- (Stratagene). Three individual
clones were sequenced: they corresponded to the 711 bp
full coding sequence and a shorter 594 bp sequence with
an internal deletion. Each of the two longer clones con-
tained a single base difference from the consensus of the
three, which were corrected by PCR directed mutagenesis.
RT-PCR analysis
COS-1 cells were transfected with pCMV5-Flag mouse
Tgif2, human TGIF2, or mouse/human chimeras. RNA
was isolated using an Absolutely RNA kit (Stratagene),
and RT-PCR was carried out with Ready To Go PCR beads
(Amersham Paharmacia Biotech). Analysis of Tgif2
expression in mouse tissues was carried out by PCR, from
first strand cDNAs (Clontech). PCR products were ana-
lyzed by agarose gel electrophoresis and southern blot for
quantification.
Luciferase assays
36–40 h after transfection, cells were lysed in Promega
passive lysis buffer and assayed for luciferase activity with
a Berthold LB 953 luminometer. A pCMVh Renilla luci-
ferase reporter (Promega) was included in all transfec-
tions to monitor transfection efficiency. Firefly luciferase
was assayed using a luciferase assay kit (Promega) and
Renilla luciferase activity was assayed with 0.09 µM coe-
lenterazine (Biosynth) in 25 mM Tris, pH 7.5,100 mM
NaCl.
Immunoprecipitation and western blotting
36 h after transfection, COS-1 cells were lysed by sonica-
tion in 100 mM NaCl, 50 mM HEPES, pH 7.8,20% glyc-
erol, 0.1% Tween 20,0.5% NP40 with protease and
phosphatase inhibitors. Immunocomplexes were col-
lected on Flag M2-agarose (Sigma). Following SDS-PAGE,
proteins were electroblotted to Immobilon-P (Millipore),
incubated with antisera specific for: Flag (Sigma), Myc
(9E10; Sigma), or Smad2/Smad3 (Upstate), and visual-
ized with horseradish peroxidase-conjugated goat anti-
mouse or anti-rabbit Ig (Pierce) and ECL (Amersham
Pharmacia Biotech).
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